SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-19-006935
Filing Date
2019-06-05
Accepted
2019-06-04 21:45:23
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3/A azrxs3a_2019.htm S-3/A 58553
2 OPINION ON LEGALITY ex5-1.htm EX-5 12804
3 CONSENTS OF EXPERTS AND COUNSEL ex23-2.htm EX-23 5390
4 IMAGE dlg.jpg GRAPHIC 9075
  Complete submission text file 0001654954-19-006935.txt   90423
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-3/A | Act: 33 | File No.: 333-231035 | Film No.: 19878455
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1